NSE BSE
fortis malar hospitals limited stock

FORTIS MALAR HOSPITALS LIMITED Share Price

- - (%)
Sector: -

523696

FORTISMLR

img img img img
No Data Available

FORTIS MALAR HOSPITALS LIMITED Share Price Update


As of the latest trading session, FORTIS MALAR HOSPITALS LIMITED share price is currently at 70.06, which is down by -1.42 from its previous closing. Today, the stock has fluctuated between 70.06 and 70.06. Over the past year, FORTIS MALAR HOSPITALS LIMITED has achieved a return of 42.33 %. In the last month alone, the return has been -19.87 %.

FORTIS MALAR HOSPITALS LIMITED Performance

Day Range

Low70.06 High70.06
74.41

52 Week Range

Low 44.00 High 107.94
74.41

Open Price

70.06

Prev. Close

71.48

Volume (Shares)

5244.00

Total traded value

3.90

Upper Circuit

75.89

Lower Circuit

72.93

Note: The current prices & values are delayed, Login to your account for live updates.

FORTIS MALAR HOSPITALS LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 131.30
PE Ratio (TTM) 0.00
Book Value / Share 30.44
Beta 0.17
ROE -22.20%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) 56.04

FORTIS MALAR HOSPITALS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 5.52
Operating Expense 6.47
Net Profit 56.04
Net Profit Margin (%) 1015.21
Earnings Per Share (EPS) 29.90
EBITDA 62.15
Effective Tax Rate (%) 7.69
Particulars DEC 2023 (Values in Cr)
Revenue 17.58
Operating Expense 22.83
Net Profit -4.01
Net Profit Margin (%) -22.81
Earnings Per Share (EPS) -2.14
EBITDA 0.16
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 18.15
Operating Expense 22.25
Net Profit -1.81
Net Profit Margin (%) -9.97
Earnings Per Share (EPS) -0.96
EBITDA 2.21
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 17.76
Operating Expense 22.29
Net Profit -2.94
Net Profit Margin (%) -16.55
Earnings Per Share (EPS) -1.57
EBITDA 1.08
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 20.66
Operating Expense 24.79
Net Profit -7.01
Net Profit Margin (%) -33.93
Earnings Per Share (EPS) -3.74
EBITDA 2.67
Effective Tax Rate (%) -219.63
Particulars MAR 2024 (Values in Cr)
Revenue 59.01
Operating Expense 73.86
Net Profit 47.28
Net Profit Margin (%) 80.12
Earnings Per Share (EPS) 25.23
EBITDA 65.61
Effective Tax Rate (%) 8.98
Particulars MAR 2023 (Values in Cr)
Revenue 85.95
Operating Expense 99.59
Net Profit -15.53
Net Profit Margin (%) -18.06
Earnings Per Share (EPS) -8.29
EBITDA 11.14
Effective Tax Rate (%) -119.49
Particulars MAR 2022 (Values in Cr)
Revenue 86.18
Operating Expense 101.82
Net Profit -8.31
Net Profit Margin (%) -9.64
Earnings Per Share (EPS) -4.43
EBITDA 10.77
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 69.24
Operating Expense 95.64
Net Profit -8.01
Net Profit Margin (%) -11.56
Earnings Per Share (EPS) -4.28
EBITDA 8.61
Effective Tax Rate (%) 30.07
Particulars MAR 2020 (Values in Cr)
Revenue 111.87
Operating Expense 134.95
Net Profit -9.06
Net Profit Margin (%) -8.09
Earnings Per Share (EPS) -4.83
EBITDA 8.18
Effective Tax Rate (%) 25.49
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.21
ROE % -21.45
ROCE % -0.75
Total Debt to Total Equity 0.69
EBITDA Margin 13.04
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.72
ROE % -9.79
ROCE % -1.19
Total Debt to Total Equity 0.65
EBITDA Margin 12.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 47.31
ROE % -15.90
ROCE % -7.05
Total Debt to Total Equity 0.66
EBITDA Margin 2.76
Particulars MAR 2020 (Values in Cr)
Book Value / Share 51.40
ROE % -8.81
ROCE % -3.05
Total Debt to Total Equity 0.32
EBITDA Margin 7.52
Particulars MAR 2019 (Values in Cr)
Book Value / Share 56.18
ROE % 1.98
ROCE % 3.13
Total Debt to Total Equity 0.00
EBITDA Margin 5.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 33.03
ROE % -22.20
ROCE % -0.81
Total Debt to Total Equity 0.71
EBITDA Margin 12.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 41.57
ROE % -10.10
ROCE % -1.25
Total Debt to Total Equity 0.67
EBITDA Margin 12.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 46.18
ROE % -16.42
ROCE % -7.24
Total Debt to Total Equity 0.67
EBITDA Margin 2.54
Particulars MAR 2020 (Values in Cr)
Book Value / Share 50.34
ROE % -9.15
ROCE % -3.27
Total Debt to Total Equity 0.32
EBITDA Margin 7.32
Particulars MAR 2019 (Values in Cr)
Book Value / Share 55.23
ROE % 1.70
ROCE % 2.76
Total Debt to Total Equity 0.00
EBITDA Margin 5.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.43
Total Assets 137.99
Total Liabilities 137.99
Total Equity 64.17
Share Outstanding 18741759
Price to Book Ratio 1.44
Return on Assets (%) -11.21
Return on Capital (%) -24.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.55
Total Assets 160.91
Total Liabilities 160.91
Total Equity 80.13
Share Outstanding 18741759
Price to Book Ratio 1.39
Return on Assets (%) -5.14
Return on Capital (%) -10.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.56
Total Assets 169.09
Total Liabilities 169.09
Total Equity 88.74
Share Outstanding 18741759
Price to Book Ratio 1.20
Return on Assets (%) -4.65
Return on Capital (%) -8.87
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 43.25
Total Assets 193.54
Total Liabilities 193.54
Total Equity 96.40
Share Outstanding 18741759
Price to Book Ratio 0.85
Return on Assets (%) -4.59
Return on Capital (%) -9.22
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 6.64
Total Assets 150.85
Total Liabilities 150.85
Total Equity 105.37
Share Outstanding 18741759
Price to Book Ratio 1.00
Return on Assets (%) 1.36
Return on Capital (%) 1.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.30
Total Assets 135.69
Total Liabilities 135.69
Total Equity 61.95
Share Outstanding 18741759
Price to Book Ratio 1.44
Return on Assets (%) -11.44
Return on Capital (%) -25.07
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 10.48
Total Assets 158.67
Total Liabilities 158.67
Total Equity 77.97
Share Outstanding 18741759
Price to Book Ratio 1.39
Return on Assets (%) -5.23
Return on Capital (%) -10.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.60
Total Assets 166.98
Total Liabilities 166.98
Total Equity 86.61
Share Outstanding 18741759
Price to Book Ratio 1.20
Return on Assets (%) -4.79
Return on Capital (%) -9.25
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 41.71
Total Assets 191.41
Total Liabilities 191.41
Total Equity 94.42
Share Outstanding 18741759
Price to Book Ratio 0.85
Return on Assets (%) -4.73
Return on Capital (%) -9.59
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 6.64
Total Assets 148.49
Total Liabilities 148.49
Total Equity 103.59
Share Outstanding 18741759
Price to Book Ratio 1.00
Return on Assets (%) 1.16
Return on Capital (%) 1.68
Particulars MAR 2023 (Values in Cr)
Net Income -7.00
Cash from Operations 5.52
Cash from Investing 0.49
Cash from Financing -12.65
Net change in Cash -6.54
Free Cash Flow 7.40
Particulars MAR 2022 (Values in Cr)
Net Income -8.26
Cash from Operations 7.56
Cash from Investing 8.23
Cash from Financing -10.10
Net change in Cash 4.97
Free Cash Flow 8.96
Particulars MAR 2021 (Values in Cr)
Net Income -11.31
Cash from Operations -12.95
Cash from Investing -27.51
Cash from Financing -7.24
Net change in Cash -35.62
Free Cash Flow -12.42
Particulars MAR 2020 (Values in Cr)
Net Income -11.93
Cash from Operations 3.86
Cash from Investing 49.88
Cash from Financing -11.56
Net change in Cash 38.01
Free Cash Flow 7.17
Particulars MAR 2019 (Values in Cr)
Net Income 2.79
Cash from Operations -10.76
Cash from Investing 6.34
Cash from Financing 0.15
Net change in Cash -9.47
Free Cash Flow -8.05
Particulars MAR 2023 (Values in Cr)
Net Income -7.07
Cash from Operations 5.51
Cash from Investing 0.43
Cash from Financing -12.65
Net change in Cash -6.60
Free Cash Flow 7.39
Particulars MAR 2022 (Values in Cr)
Net Income -8.30
Cash from Operations 7.47
Cash from Investing 8.17
Cash from Financing -10.10
Net change in Cash 4.87
Free Cash Flow 8.88
Particulars MAR 2021 (Values in Cr)
Net Income -11.46
Cash from Operations -12.85
Cash from Investing -27.60
Cash from Financing -7.24
Net change in Cash -36.04
Free Cash Flow -12.32
Particulars MAR 2020 (Values in Cr)
Net Income -12.15
Cash from Operations 4.34
Cash from Investing 48.30
Cash from Financing -11.56
Net change in Cash 36.47
Free Cash Flow 7.65
Particulars MAR 2019 (Values in Cr)
Net Income 2.35
Cash from Operations -11.19
Cash from Investing 6.10
Cash from Financing 0.15
Net change in Cash -9.47
Free Cash Flow -8.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
FORTIS MALAR HOSPITALS LIMITED 70.06 0.00 2.21 131.30 44.00 / 107.94
APOLLO HOSPITALS ENTER. L 5956.95 108.68 13.17 85651.80 4410.05 / 6871.30
SHREE PACETRONIX LTD. 217.00 20.11 6.97 78.11 121.60 / 391.90
TRANSGENE BIOTEK LTD. 6.45 0.00 4.40 48.87 3.62 / 12.46
MEDINOVA DIAGNOSTIC SERVICES L 36.60 18.30 -11.79 36.53 21.90 / 64.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
FORTIS MALAR HOSPITALS LIMITED 70.06 0.00 2.30 131.30 44.00 / 107.94
APOLLO HOSPITALS ENTER. L 5956.95 85.77 11.74 85651.80 4410.05 / 6871.30
Fortis Malar Hospitals Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 34.34 95.39 143.86 25.65 19.50 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 4066.85 28.14 5.69 4449.13 1968.15 / 4271.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 74.10
  • 26 Days 76.30
  • 10 Days 77.50
  • 50 Days 70.20
  • 12 Days 78.90
  • 100 Days 65.10
  • 20 Days 80.90
  • 200 Days 58.80
71.48
PIVOT
First Resistance 71.48
Second Resistance 71.48
Third Resistance 71.48
First Support 71.48
Second Support 71.48
Third Support 71.48
RSI 30.20
MACD 2.61
Commodity Channel Index (CCI) -102.93
ADX 11.50
Williams % R -100.00

Over 1 Month

down

-19.87

Over 3 Months

down

28.21

Over 6 Months

down

-2.50

Over 1 Year

down

42.33

Over 3 Years

down

3.94

Over 5 Years

down

6.04

FORTIS MALAR HOSPITALS LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

FORTIS MALAR HOSPITALS LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
37.22
Promoter Holdings
62.7
FII
0.0
DII
0.07
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Fortis Hospitals Limited Shareholding of Promoter and Promoter Group 1.1752402E7 62.71
Nithya Ramamurthy Public Shareholding 859377.0 4.59
Ruckmani Natarajan Public Shareholding 387960.0 2.07
Sunita Kantilal Vardhan Public Shareholding 247934.0 1.32
A M Gopalan Public Shareholding 231028.0 1.23

FORTIS MALAR HOSPITALS LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2015-09-14 0.5 Final 2015-09-16 Equity shares 2013-09-19 0.5 Interim 2013-09-20 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About FORTIS MALAR HOSPITALS LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by FORTIS MALAR HOSPITALS LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Fortis Malar Hospitals Ltd?

Answer Field

The share price of Fortis Malar Hospitals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 70.06.

What is the Market Cap of Fortis Malar Hospitals Ltd?

Answer Field

The market cap of Fortis Malar Hospitals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 131.30 Cr. as of now.

What is the 52 Week High and Low of Fortis Malar Hospitals Ltd?

Answer Field

The 52 Week High and Low of Fortis Malar Hospitals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 107.94 and ₹ 44.00.

How to Buy Fortis Malar Hospitals Ltd share?

Answer Field

You can trade in Fortis Malar Hospitals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Fortis Malar Hospitals Ltd?

Answer Field

The 1 year returns on the stock has been 42.33%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader